Search
Clearpoint Neuro Inc
CLPTAdd to Watchlist
18.720USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
561.35MMarket Cap
LossP/E TTM
More Details of Clearpoint Neuro Inc Company
ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.
Clearpoint Neuro Inc Info
Ticker SymbolCLPT
Company nameClearpoint Neuro Inc
IPO dateJul 03, 2019
CEOBurnett (Joseph Michael)
Number of employees115
Security typeOrdinary Share
Fiscal year-endJul 03
Address120 S. Sierra Avenue
CitySOLANA BEACH
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92075
Phone19499006833
Websitehttps://www.clearpointneuro.com/
Ticker SymbolCLPT
IPO dateJul 03, 2019
CEOBurnett (Joseph Michael)
Company Executives of Clearpoint Neuro Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
310.07K
--
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
87.32K
-6.06%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
67.34K
+33.96%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
48.23K
+15.19%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
46.94K
-7.63%
Mr. Pascal E.R. Girin
Mr. Pascal E.R. Girin
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. B. Kristine (Kris) Johnson
Ms. B. Kristine (Kris) Johnson
Independent Director
Independent Director
--
--
Mr. Danilo D' Alessandro
Mr. Danilo D' Alessandro
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Linda M. Liau
Dr. Linda M. Liau
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
310.07K
--
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
87.32K
-6.06%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
67.34K
+33.96%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
48.23K
+15.19%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
46.94K
-7.63%
Mr. Pascal E.R. Girin
Mr. Pascal E.R. Girin
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of Clearpoint Neuro Inc?
The top five shareholders of Clearpoint Neuro Inc are: Mr. Joseph Michael Burnett
How many institutions hold shares of Clearpoint Neuro Inc (CLPT)?
As of 2026Q1, 266 institutions hold shares of Clearpoint Neuro Inc, with a combined market value of approximately 15.83M, accounting for 52.78% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 1860542.00.
What is the biggest source of revenue for Clearpoint Neuro Inc?
In 2026Q1, the Products: Functional neurosurgery business generated the highest revenue for Clearpoint Neuro Inc, amounting to 14.83M and accounting for 40.12% of total revenue.